Annual Total Liabilities
$68.50 M
+$33.54 M+95.93%
December 31, 2023
Summary
- As of February 7, 2025, TARS annual total liabilities is $68.50 million, with the most recent change of +$33.54 million (+95.93%) on December 31, 2023.
- During the last 3 years, TARS annual total liabilities has risen by +$62.51 million (+1043.24%).
- TARS annual total liabilities is now at all-time high.
Performance
TARS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$138.82 M
+$14.22 M+11.41%
September 30, 2024
Summary
- As of February 7, 2025, TARS quarterly total liabilities is $138.82 million, with the most recent change of +$14.22 million (+11.41%) on September 30, 2024.
- Over the past year, TARS quarterly total liabilities has increased by +$70.31 million (+102.64%).
- TARS quarterly total liabilities is now at all-time high.
Performance
TARS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
TARS Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +95.9% | +102.6% |
| 3 y3 years | +1043.2% | +102.6% |
| 5 y5 years | +1730.2% | +102.6% |
TARS Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +462.6% | at high | +1040.0% |
| 5 y | 5-year | at high | +1043.2% | at high | +3485.1% |
| alltime | all time | at high | +1730.2% | at high | +3485.1% |
Tarsus Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $138.82 M(+11.4%) |
| Jun 2024 | - | $124.60 M(+68.2%) |
| Mar 2024 | - | $74.07 M(+8.1%) |
| Dec 2023 | $68.50 M(+95.9%) | $68.50 M(+25.3%) |
| Sep 2023 | - | $54.67 M(+32.7%) |
| Jun 2023 | - | $41.20 M(+9.0%) |
| Mar 2023 | - | $37.81 M(+8.1%) |
| Dec 2022 | $34.96 M | $34.96 M(+3.3%) |
| Sep 2022 | - | $33.84 M(+8.0%) |
| Jun 2022 | - | $31.32 M(-3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $32.29 M(+165.1%) |
| Dec 2021 | $12.18 M(+103.2%) | $12.18 M(+8.0%) |
| Sep 2021 | - | $11.27 M(+2.7%) |
| Jun 2021 | - | $10.98 M(+2.4%) |
| Mar 2021 | - | $10.72 M(+78.9%) |
| Dec 2020 | $5.99 M(-90.7%) | $5.99 M(-94.6%) |
| Sep 2020 | - | $110.01 M(+2741.3%) |
| Jun 2020 | - | $3.87 M(-94.0%) |
| Dec 2019 | $64.32 M(+1618.4%) | $64.32 M |
| Dec 2018 | $3.74 M | - |
FAQ
- What is Tarsus Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual total liabilities year-on-year change?
- What is Tarsus Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly total liabilities year-on-year change?
What is Tarsus Pharmaceuticals annual total liabilities?
The current annual total liabilities of TARS is $68.50 M
What is the all time high annual total liabilities for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual total liabilities is $68.50 M
What is Tarsus Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, TARS annual total liabilities has changed by +$33.54 M (+95.93%)
What is Tarsus Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of TARS is $138.82 M
What is the all time high quarterly total liabilities for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly total liabilities is $138.82 M
What is Tarsus Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, TARS quarterly total liabilities has changed by +$70.31 M (+102.64%)